NCT05467709View on ClinicalTrials.gov

Study To Evaluate The Effect Of Multiple Doses of CTP-543 On The Pharmacokinetics Of Single Doses of Midazolam In Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

June 21, 2022

Primary Completion Date

June 30, 2022

Study Completion Date

July 7, 2022

Conditions
Health Volunteers
Interventions
DRUG

Midazolam

2 mg Day 1 and Day 16

DRUG

CTP-543

12 mg q12 hour for 14 consecutive days starting on Day 3

Trial Locations (1)

33014

Clinical Pharmacology of Miami, LLC, Miami

Sponsors
All Listed Sponsors
lead

Concert Pharmaceuticals

INDUSTRY

NCT05467709 - Study To Evaluate The Effect Of Multiple Doses of CTP-543 On The Pharmacokinetics Of Single Doses of Midazolam In Healthy Subjects | Biotech Hunter | Biotech Hunter